Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000930

Drug Information
SynonymsEstazolam (JP15/USAN/INN); DB01215; Julodin; 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; BIDD:GT0481; LS-7378; Takeda Brand of Estazolam; BRN 1220868; ProSom; CID3261; AKOS005064373; Abbott Brand of Estazolam; Prosom (TN); Tasedan; Estazolam [USAN:INN:JAN]; I06-0352; DEA No. 2756; AC1L1FJ8; 4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-; Eurodin; Somnatrol; InChI=1/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2; 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-; D004949; Estazolamum [INN-Latin]; D00311; UNII-36S3EQV54C; ZINC00001370; 8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine; MolPort-003-941-274; CHEMBL285674; D40TA; CCRIS 1955; E3638_SIGMA; C16H11ClN4; U 33737; D-40TA; Hormona Brand of Estazolam; 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-; D 40TA; estazolam; Nuctalon; 8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine; NSC290818; Estazolamum; 8-chloro-6-phenyl-4H-s-triazolo[4,3-(alpha)] [1,4]benzodiazepine; CDCHDCWJMGXXRH-UHFFFAOYSA-; 4H-s-Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-; 29975-16-4; NCGC00168250-01; CHEBI:4858; NSC 290818; Abbott 47631; Esilgan; 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl; EINECS 249-982-4; Nemurel; WLN: T B576 BN DNN HN GHJ IR& LG; 8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine (IUPAC); Cannoc
Trade NameProSom; Eurodin
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4    
Therapeutic ClassAnticonvulsants
CAS NumberCAS 29975-16-4
PubChem Compound IDCID 3261.
PubChem Substance IDSID 145301.
SuperDrug ATC IDN05CD04
SuperDrug CAS ID029975164;
TargetBenzodiazepine receptorAgonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074818 To Reference
Ref 2Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists. Bioorg Med Chem Lett. 2005 Jun 15;15(12):3126-9. To Reference
Ref 3Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists. Bioorg Med Chem. 2003 Mar 6;11(5):769-73. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543